Sun Pharma Swears By Time-tested U.S., India Markets As It Builds Specialty Business

MUMBAI – Despite the striking low profile that Sun Pharmaceutical Industries Ltd.’s Managing Director Dilip Shanghvi keeps, his flair to discuss advances in drug discovery programs impresses researchers as much as business managers. Shanghvi built the operation from a modest drug distribution outfit in India’s eastern city of Kolkata to become the country’s most valued pharmaceutical company in less than three decades.

Unlike most other leading Indian generic drug manufacturers that cast a net wide into global markets, Sun’s overall distribution of sales is dominated by U.S. and India. Of its 2013...